Ergoteles’s Neogen NEOG Stock Holding History

Ergoteles’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-56,989	Closed	-$796K	–	1734
2022 Q3	$796K	Buy	+56,989	New	+$1.15M	0.03%	576
2021 Q3	–	Sell	-14,500	Closed	-$668K	–	1528
2021 Q2	$668K	Buy	+14,500	New	+$670K	0.02%	663
2021 Q1	–	Sell	-52,484	Closed	-$2.08M	–	976
2020 Q4	$2.08M	Buy	52,484 +42,884	+447%	+$1.59M	0.07%	243
2020 Q3	$376K	Buy	+9,600	New	+$367K	0.05%	283

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Ergoteles's NEOG Position: Q4 2022 in Review

Ergoteles sold out of Neogen (NEOG) in Q4 2022, closing a stake of 56,989 shares — an estimated $796K sold.

Ergoteles first reported a position in NEOG in Q3 2020 and held it in 4 quarters. The position peaked at $2.08M in Q4 2020. 370 funds tracked by Wall St. Rank hold NEOG as of Q4 2022.

Ergoteles reported no remaining Neogen position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 56,989 Neogen shares in Q4 2022, an estimated $796K.
Ergoteles first reported a position in Neogen in Q3 2020 and held it in 4 quarters.
Ergoteles's Neogen position peaked at $2.08M in Q4 2020.
370 funds tracked by Wall St. Rank held Neogen as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.